Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-005577
Filing Date
2017-05-15
Accepted
2017-05-15 16:40:52
Documents
54
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q imuc-33117x10q.htm 10-Q 577906
2 EXHIBIT 31.1 imuc-33117xexhibit311.htm EX-31.1 13192
3 EXHIBIT 31.2 imuc-33117xexhibit312.htm EX-31.2 13228
4 EXHIBIT 32.1 imuc-33117xexhibit321.htm EX-32.1 6269
5 EXHIBIT 32.2 imuc-33117xexhibit322.htm EX-32.2 6297
  Complete submission text file 0001628280-17-005577.txt   3455306

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imuc-20170331.xml EX-101.INS 485485
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imuc-20170331.xsd EX-101.SCH 34884
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imuc-20170331_cal.xml EX-101.CAL 48584
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imuc-20170331_def.xml EX-101.DEF 158598
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imuc-20170331_lab.xml EX-101.LAB 462938
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imuc-20170331_pre.xml EX-101.PRE 281082
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35560 | Film No.: 17844978
SIC: 2834 Pharmaceutical Preparations